Navigation Links
ULURU Inc. Announces Poster Presentations at the 23rd Annual 'Clinical Symposium on Advances in Skin & Wound Care'
Date:10/28/2008

ADDISON, Texas, Oct. 28 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) today announced that it will present two posters at the "Clinical Symposium on Advances in Skin and Wound Care" being held in Las Vegas from October 27 to October 30, 2008.

The principal author on the poster titled, "Altrazeal(TM), A Transforming Powder Wound Dressing: The Clinical Experience" (poster #153) is Dr. Jeffrey A. Niezgoda, M.D., FACHM, FAPWCA, Director of the Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy, Aurora Health Care. Several case studies are presented to illustrate the dynamic clinical benefits of this novel technology. The early clinical experience demonstrates excellent patient toleration and improved wound healing. Additional benefits include ease of application and a reduction in dressing changes with or without a secondary dressing.

The second poster (poster #154) is titled "The Design and Performance of Nanoflex(TM) Transforming Powder Dressing: A Novel Wound Care Management System". John V. St. John, Ph.D., Vice President of Material Science at ULURU Inc. and a co-inventor of this proprietary technology is the principal author of this poster which describes the physical properties of the dressing, pre-clinical data and a patient case study. The design features of Altrazeal(TM), which are unique to this material, including the high moisture vapor transpiration rate, fluid uptake and material strength are presented on this poster.

Altrazeal(TM), a transforming powder dressing, which is produced using our Nanoflex(TM) Technology, is a breakthrough new treatment for exuding wounds including burns, trauma, skin graft donor sites, surgical wounds and chronic slow-healing wounds such as diabetic foot ulcers, pressure ulcers and venous ulcers. Altrazeal(TM) is designed to provide greater effectiveness in wound closure by promoting an optimal moist wound healing environment. Altrazeal(TM) provides additional patient benefits including reduced pain and enhanced patient comfort, ease of application and removal and in most cases it does not require a secondary dressing.

Dr. Jeffery Niezgoda stated, "I am very pleased to be the first to present clinical data on this revolutionary new technology. My early clinical experience with Altrazeal(TM) has produced exceptional results with improved wound healing trajectories. Clinical success has been achieved in a series of patients with a variety of wound types and I look forward to presenting this exciting data."

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Nanoflex(TM) Aggregate technology. For further information about ULURU Inc., please visit our website at http://www.uluruinc.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, including but not limited to statements made relating to the response to the product from patients, the importance of use of the product for burn victims, the ability to use the product for chronic wounds, the perception of the product as a transformational innovation in the wound care market, the product accelerates healing and decreases pain and dressing changes. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007, Quarterly Report on Form 10-Q for the quarter ended June 30, 2008 and other reports filed by us with the Securities and Exchange Commission.

Contact: Company Media Contact:

Kerry P. Gray Stephen Zoegall, Ph.D.

President & CEO Berry & Co. Public Relations

Terry K. Wallberg (212) 253-8881

Vice President & CFO szoegall@berrypr.com

(214) 905-5145


'/>"/>
SOURCE ULURU Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
2. ULURU Inc. Announces Odd-Lot Buy Back Offer
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
4. ULURU Inc. Reports Third Quarter 2007 Results
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
9. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
10. ULURU Inc. Reports First Quarter 2008 Financial Results
11. ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... series, Innovations with Ed Begley, Jr., scheduled to broadcast Saturday, January 28, 2017 ... which was founded in 2008 to address the limitations of fatigue monitoring technologies ...
(Date:1/23/2017)... ... , ... Sharon Kleyne, America’s leading water researcher, advocate and feared enemy of ... making new water infrastructure a number one priority. “As we usher in a new ... to become a top priority of our new political change agents.” Kleyne pointed out ...
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture measurement ... the right method is paramount to success. Selecting an inappropriate measurement method can ... multiple persons use the same equipment. Rare or expensive substances are wasted and ...
(Date:1/23/2017)... ROSEMONT, IL (PRWEB) , ... ... ... Research and Education Foundation (OREF), in partnership with the American Society of ... Patient Safety Foundation (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and ...
(Date:1/23/2017)... (PRWEB) , ... January 23, ... ... Partnership (SNP) has launched online education programs and resources at seafoodnutrition.org/programs and ... nutritional benefits of a seafood-rich diet. These resources have been developed for ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... , January 23, 2017 Ahead of ... to see how they have fared at the close: Kite Pharma ... Inc. (NASDAQ: OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... Biotechnology shares were relative laggards on Friday, January 20 th , ... our complimentary research reports on these stocks now at: ...
(Date:1/23/2017)... 2017  ResMed (NYSE : RMD), BMC (Pékin, Chine) et ... aujourd,hui qu,ils se sont mis d,accord sur le règlement ... BMC et 3B seront autorisés à vendre leurs produits ... et ResMed effectuera le paiement de la décision en ... de Floride entre les deux parties. Le règlement n,inclut ...
(Date:1/23/2017)... Jan. 23, 2017 Just two weeks remain until legal experts ... gather in Central London to discuss the flow ... in the market, Parallel Trade 2017 . In the ... of attendees which is available to read in the event download ... Some of ...
Breaking Medicine Technology: